S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
MP
INSIDER · ETON · Eton Pharmaceuticals, Inc. · DIRECTOR

MAIER PAUL V

Every open-market transaction filed under this name, Aug 28 to Aug 28.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$3M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 28ETONEton Pharmaceuticals, Inc.DirectorSell128$61.77$8K−2.2%
Aug 28ETONEton Pharmaceuticals, Inc.DirectorSell13,485$60.21$812K+0.4%
Aug 28ETONEton Pharmaceuticals, Inc.DirectorSell36,387$58.64$2.1M+3.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.